IFNλ3 (IL-28B) concentrations in supernatants were significantly greater following HRV-16 as compared to SARS-CoV-2 WA-01 infection at both 48 h (median 1335 vs. 40.6 pg/mL, p < 0.001, Fig. 3B) and 96 h (median 197 vs. 48 pg/mL, p < 0.001, Fig. 3B). This evidence concerns the gene IFNL3 and infection.